Efficacy and Effectiveness of Combination Therapy With Pegylated Interferon Alfa-2a and Ribavirin in Korean Patients With Chronic Hepatitis C
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Pharmacogenomic; Therapeutic Use
- 16 May 2012 Planned number of patients changed from 272 to NULL.
- 16 May 2012 New trial record
- 15 May 2012 Biomarkers information updated